Misplaced Pages

Paola Leone: Difference between revisions

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively← Previous editNext edit →Content deleted Content addedVisualWikitext
Revision as of 13:49, 11 September 2018 editSer Amantio di Nicolao (talk | contribs)Autopatrolled, Administrators6,299,281 editsm add authority control, testTag: AWB← Previous edit Revision as of 00:36, 23 October 2018 edit undoT0mpr1c3 (talk | contribs)Extended confirmed users11,617 edits categoriesNext edit →
Line 7: Line 7:
==References== ==References==
{{Reflist}} {{Reflist}}



{{authority control}} {{authority control}}
⚫ {{DEFAULTSORT:Leone, Paola}}


⚫ {{DEFAULTSORT:Leone, Paola}}
] ]
] ]
Line 18: Line 17:
] ]
] ]
] ]
] ]
]
]
]
]
]
] ]
] ]



{{italy-med-bio-stub}} {{italy-med-bio-stub}}

Revision as of 00:36, 23 October 2018

Paola Leone, Ph.D., is a leading researcher of Canavan disease.

Dr. Leone was born and raised in Cagliari, Italy. She received her undergraduate and graduate training in Italy, followed by post-doctoral studies in Montreal and Yale University in New Haven, CT. She holds a doctorate degree in Neuroscience from the University of Padua. Her work on Canavan disease started at Yale, where she collaborated with other early pioneers in gene therapy. She left Yale in 1998 to co-direct the (now defunct) Cell & Gene Therapy Center at Thomas Jefferson University in Philadelphia, PA. She now directs The Cell & Gene Therapy Center at the University of Medicine and Dentistry of New Jersey.

Recently, she has been funded by NIH-NINDS and Jacob's Cure to study the potential of subpopulations of stem cells to promote remyelination and phenotypic rescue in animal models of white matter disease, including the Canavan mouse model. She is currently generating pre-clinical data using human Embryonic-Derived-Oligodendrocyte Stem Cells provided by Geron Corporation (CA). These studies will provide a foundation for a targeted and comprehensive analysis of the potential of a cell-based therapy for Canavan Disease.

References

  1. University of Medicine and Dentistry of New Jersey - Faculty and Research Interests
  2. University of Medicine and Dentistry of New Jersey - Cell and Gene Therapy Center Faculty and Staff Archived 2009-03-25 at archive.today.
  3. Jacob's Cure Canavan Disease Research -
Stub icon

This biography related to medicine in Italy is a stub. You can help Misplaced Pages by expanding it.

Categories: